Clinical Trial

International Study on Treatment of Liver (HCC) Patients With IRE

Study acronym: LIVERHCC-IRE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Procedural data will be recorded from patients with liver lesions from hepatocellular cancer who have been assessed by an appropriately constituted MDT (or equivalent) as appropriate to receive irreversible electroporation
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-23.
Trial Details
NCT Number NCT07192731
Lead Sponsor Angiodynamics, Inc.
Conditions Hepatocellular Carcinoma (HCC), Liver Ablation, Liver Cancer, Adult
Enrollment 50 participants
Start Date 2026-02
Primary Completion 2028-02 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2025-10-10